Matches in DBpedia 2015-10 for { ?s ?p "Farhad Hafezi (born 1967 in Remscheid, Germany) is a Swiss eye surgeon and researcher. From 1994 until 2004 Hafezi was recognized as a leading researcher in the field of retinal degeneration, but in 2003 he began his research on the cornea, for which he is internationally known today. In the beginning of his research career, Hafezi was part of the team to discover the first gene that was responsible for light-induced retinal degeneration. Currently, Hafezi’s clinical and laboratory research is focused on ocular cell biology, and translational research initiatives like improving refractive eye laser surgery techniques and addressing complications. Hafezi is considered a leading expert and key opinion leader in the development and translation of corneal collagen cross-linking (CXL) and its multiple applications in the field of ophthalmology, including its application to treat corneal infection (PACK-CXL).Hafezi has published over 150 articles in various peer-reviewed scientific journals since 1997, including Nature Medicine, Nature Genetics, Investigative Ophthalmology & Visual Science and Cell Death & Differentiation.His most recent work in the field of corneal collagen cross-linking, has led him to receive a number of international awards. In 2014, his peers ranked Hafezi as one of the top 100 most influential people in ophthalmology."@en }
Showing triples 1 to 1 of
1
with 100 triples per page.
- Farhad_Hafezi abstract "Farhad Hafezi (born 1967 in Remscheid, Germany) is a Swiss eye surgeon and researcher. From 1994 until 2004 Hafezi was recognized as a leading researcher in the field of retinal degeneration, but in 2003 he began his research on the cornea, for which he is internationally known today. In the beginning of his research career, Hafezi was part of the team to discover the first gene that was responsible for light-induced retinal degeneration. Currently, Hafezi’s clinical and laboratory research is focused on ocular cell biology, and translational research initiatives like improving refractive eye laser surgery techniques and addressing complications. Hafezi is considered a leading expert and key opinion leader in the development and translation of corneal collagen cross-linking (CXL) and its multiple applications in the field of ophthalmology, including its application to treat corneal infection (PACK-CXL).Hafezi has published over 150 articles in various peer-reviewed scientific journals since 1997, including Nature Medicine, Nature Genetics, Investigative Ophthalmology & Visual Science and Cell Death & Differentiation.His most recent work in the field of corneal collagen cross-linking, has led him to receive a number of international awards. In 2014, his peers ranked Hafezi as one of the top 100 most influential people in ophthalmology.".